LENALIDOMIDE plus LOW-DOSE DEXAMETHASONE (RD) VS. MELPHALAN-PREDNISONE-THALIDOMIDE (MPT) IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) PATIENTS (PTS): THE FIRST TRIAL

Thierry Façon; Meletios A Dimopoulos; Angela Dispenzieri; J. Catalano; Andrew R. Belch; C. Hulin; Michèle Cavo; A. De Lorenzo Pinto; Katja Weisel; H. Ludwig; NJ Bahlis; A. Baños; Mourad Tiab; Michel Delforge; John Cavenagh; Catarina Geraldes; J. J Lee; C Chen; Albert Oriol; Javier de la Rubia; Lugui Qiu; Darell White; D. Binder; Kendra Anderson; Philippe Moreau; Michel Attal; R. Knight; G Chen; Jason Van Oostendorp; Christian Jacques; Annette Ervin‐Haynes; Lotfi Benboubker

Related publications

Article2014

Impact of Renal Impairment (RI) on Outcomes after Treatment (Tx) with Lenalidomide and Low-Dose Dexamethasone (Rd) in Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts): First Trial Results

Meletios A Dimopoulos, Matthew C. Cheung, Murielle Roussel, Ting Liu, Barbara Gamberi, Brigitte Kolb, Hans Guenter Derigs, Hyeon Seok Eom, Karim Belhadj, Pascal Lenain, Richard H. van der Jagt, Sophie Rigaudeau, Mamoun Dib, R. Hall, Arnaud Jaccard, Axel Tosikyan, Lionel Karlin, William Bensinger, Rik Schots, Guang Chen, Jennifer Marek, Annette Ervin‐Haynes, Thierry Façon

Article2015

Effect of age on efficacy and safety outcomes in patients with newly diagnosed multiple myeloma receiving lenalidomide and low-dose dexamethasone (RD): the first trial

C. Hulin, Chaim Shustik, Andrew R. Belch, MT Petrucci, Ulrich Duehrsen, Jiamei Lu, Kihwan Song, Philippe Rodon, Brigitte Pegourié, Laurent Garderet, HM Hunter, I Azaïs, Richard Eek, Margaret Macro, Shaker R. Dakhil, Houck, G Chen, Annette Ervin‐Haynes, Fritz Offner, Meletios A Dimopoulos, Thierry Façon

Article2017

Phase 3 Study (CLARION) of Carfilzomib, Melphalan, Prednisone (KMP) v Bortezomib, Melphalan, Prednisone (VMP) in Newly Diagnosed Multiple Myeloma (NDMM)

Thierry Façon, Jae Hoon Lee, Philippe Moreau, Rubén Niesvizky, Meletios A Dimopoulos, Roman Hájek, Muhtarjan Osman, Sanjay Aggarwal, Zandra Klippel, Jesús F. San Miguel

Article2015

Continuous Lenalidomide and Low-Dose Dexamethasone for the Treatment of Patients with Newly Diagnosed Multiple Myeloma and Renal Impairment in the First Trial

Meletios A Dimopoulos, Matthew C. Cheung, Murielle Roussel, Ting Liu, Barbara Gamberi, Brigitte Kolb, Hans Günter Derigs, Hyeon‐Seok Eom, Karim Belhadj, Pascal Lenain, Richard van der Jagt, Sophie Rigaudeau, R. Hall, Arnaud Jaccard, Axel Tosikyan, Lionel Karlin, Jack W. Singer, Rik Schots, G. Chen, J Marek, Annette Ervin‐Haynes, Thierry Façon

Letter2008

Thalidomide plus dexamethasone as primary therapy for newly diagnosed patients with multiple myeloma

Meletios A Dimopoulos, Efstathios Kastritis